[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416-346-7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.35, "open": 3.29, "dayLow": 3.075, "dayHigh": 3.37, "regularMarketPreviousClose": 3.35, "regularMarketOpen": 3.29, "regularMarketDayLow": 3.075, "regularMarketDayHigh": 3.37, "payoutRatio": 0.0, "beta": 0.219, "trailingPE": 0.0783046, "volume": 111058, "regularMarketVolume": 111058, "averageVolume": 1692051, "averageVolume10days": 5947440, "averageDailyVolume10Day": 5947440, "bid": 2.37, "ask": 3.98, "bidSize": 2, "askSize": 2, "marketCap": 2332268, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 334.8, "fiftyDayAverage": 5.25122, "twoHundredDayAverage": 11.773605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5902113, "profitMargins": 0.0, "floatShares": 66425, "sharesOutstanding": 713232, "sharesShort": 6096, "sharesShortPriorMonth": 20747, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0085, "heldPercentInsiders": 0.00483, "heldPercentInstitutions": 0.44686002, "shortRatio": 0.0, "shortPercentOfFloat": 0.0086, "impliedSharesOutstanding": 713232, "bookValue": 94.317, "priceToBook": 0.034670312, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.613, "52WeekChange": -0.98994464, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 3.27, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "regularMarketChangePercent": -2.38806, "regularMarketPrice": 3.27, "ipoExpectedDate": "2024-01-26", "prevName": "Psyence Therapeutics Corp.", "nameChangeDate": "2025-08-15", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "corporateActions": [], "postMarketTime": 1755300971, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.183488, "postMarketPrice": 3.276, "postMarketChange": 0.00600004, "regularMarketChange": -0.0799999, "regularMarketDayRange": "3.075 - 3.37", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1692051, "fiftyTwoWeekLowChange": 0.9100001, "fiftyTwoWeekLowChangePercent": 0.38559327, "fiftyTwoWeekRange": "2.36 - 334.8", "fiftyTwoWeekHighChange": -331.53, "fiftyTwoWeekHighChangePercent": -0.990233, "fiftyTwoWeekChangePercent": -98.99446, "epsTrailingTwelveMonths": 41.76, "fiftyDayAverageChange": -1.9812202, "fiftyDayAverageChangePercent": -0.3772876, "twoHundredDayAverageChange": -8.503605, "twoHundredDayAverageChangePercent": -0.72226006, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]